1Henle G, Henle W. Epstein - Barr Virus - Specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer, 1976,17:1-7.
1[1]Lin JC, Chen KY, Wang WY, et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma:relationship to diatant metastasis and survival [J].J Clin Oncol, 2001,19(10):2607-2615.
2[2]Hsiao JR, Jin YT, Tsai ST. Detection of cell free Epstein-Barr virus DNA in sera from patient with nasopharyngeal carcinoma [J].Cancer,2002,94(3):723-729.
3[3]Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulation Epstein-Barr virus DNA [J].Cancer Res, 2000,60(24):6878-6881.
4[4]Ngan RK, Lau WH, Yip TT, et al. Remarkable application of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy [J]. Ann N Y Acad Sci,2001,945(1):73-79.
5[5]Yoshizaki T, Miwa H, Takeshita H, et al. Elavation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma [J]. J Cancer Res Clin Oncol, 2000,126(2):69-73.
6[6]Dardari R, Khyatti M, Benider A, et al. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma [J]. Iht J Cancer, 2000,86(1):71-75.
7[7]Yoshizaki T,Miyamori H,Hasegawa K,et al.Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth [J]. Oncogene,2000,19(14):1764-1771.
8[8]Fukuda M, Ikuta K, Yanagihara K, Tajima M, Kuratsune H, et al. Effect of transforming growth factor-betal on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines [J]. Virology,2001,288(1):109-118.
9[9]Xu J, Menezes J, Prasad U, et al. Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients [J]. Int J Cancer, 1999,84(4):396-399.
10[10]Cheng AJ, Chiu DT, See LC, et al. Poor prognosi in nasopharyngeal cancer patient with low glucose-6phosphate-dehydrogenase activity [J]. Jpn J Cancer Res, 2001,92(5):576-581.
7Shotelersuk K, Khorprasert C, Sakdikul S, et al. EpsteinBarr virus DNA in serum/plasma as a tumor marker for nasopharyngeal carcinoma[J]. Clin Cancer Res, 2000, 6 (3) : 1046.
8RAAB TRAUB N.Epstein-Barr virus in the pathogenesis of NPC[J].Semin Cancer Biol,2002,12(6):431-441.
9Raab-Traub N. Epstein-Barr Virus in the pathogenesis of NPC.Semin Cancer Biol,2002,12(6): 431~441.
10Naor D,Sionov RV,Ish-Shalom D.CD44:structure,function and association with the malignant process.Adv Cancer Res, 1997,71: 241 ~319.
